| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |